<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:b43fc1ac-9dfd-47d4-86a3-312a4f6202a7,g:fa4ae59e-aa52-4ad5-bb99-0a07ac3a7546-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="simple" xlink:href="flks-20200331.xsd#COVERPAGE"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="flks-20200331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8d437b3f-5d2e-4b52-94cd-384942087a74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_76b0eb8d-fd74-425c-8c5e-6b726dc5e1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8d437b3f-5d2e-4b52-94cd-384942087a74" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_76b0eb8d-fd74-425c-8c5e-6b726dc5e1d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd206c91-ef37-4f2b-8ed4-b625530e2a32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8d437b3f-5d2e-4b52-94cd-384942087a74" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bd206c91-ef37-4f2b-8ed4-b625530e2a32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_3fae31be-db12-4099-b748-ce5234937309" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8d437b3f-5d2e-4b52-94cd-384942087a74" xlink:to="loc_us-gaap_ReceivablesNetCurrent_3fae31be-db12-4099-b748-ce5234937309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_96e1096c-cbed-4cc2-8a68-6714cec43a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d1b45396-0a9b-4a7c-bba4-96a5f770a199" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_96e1096c-cbed-4cc2-8a68-6714cec43a1c" xlink:to="loc_us-gaap_StockholdersEquity_d1b45396-0a9b-4a7c-bba4-96a5f770a199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ae246ace-bccb-46be-8914-2f34be5e28e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_96e1096c-cbed-4cc2-8a68-6714cec43a1c" xlink:to="loc_us-gaap_Liabilities_ae246ace-bccb-46be-8914-2f34be5e28e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_0fdd8807-8704-4f9f-a6e0-d6db36206c68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_0fdd8807-8704-4f9f-a6e0-d6db36206c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7e4cd80e-54b0-4ba4-b01f-b23ee06e997a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:to="loc_us-gaap_AccountsPayableCurrent_7e4cd80e-54b0-4ba4-b01f-b23ee06e997a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_d6ccdb5b-0dc7-4057-8feb-70ee43cafa13" xlink:href="flks-20200331.xsd#flks_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:to="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_d6ccdb5b-0dc7-4057-8feb-70ee43cafa13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_b5e12d7c-1c2c-4501-8898-363941671bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:to="loc_us-gaap_NotesPayableCurrent_b5e12d7c-1c2c-4501-8898-363941671bc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f8066caa-a4b5-49e1-9819-6d132d83383b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d66fdb4c-d5bc-4049-a97d-0272ab85de92" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f8066caa-a4b5-49e1-9819-6d132d83383b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3c4dc349-d6c5-4421-b16e-bb2dc446f75f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2e96fe62-d96c-4a47-9257-593365ac14e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3c4dc349-d6c5-4421-b16e-bb2dc446f75f" xlink:to="loc_us-gaap_PreferredStockValue_2e96fe62-d96c-4a47-9257-593365ac14e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4bb74179-1bfe-469d-aabe-e7fc0294bb0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3c4dc349-d6c5-4421-b16e-bb2dc446f75f" xlink:to="loc_us-gaap_CommonStockValue_4bb74179-1bfe-469d-aabe-e7fc0294bb0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5520b0f0-dcbc-4e85-a54c-ff36e8a21798" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3c4dc349-d6c5-4421-b16e-bb2dc446f75f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5520b0f0-dcbc-4e85-a54c-ff36e8a21798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_97a39587-0ed9-4489-9483-caf57fbe2194" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3c4dc349-d6c5-4421-b16e-bb2dc446f75f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_97a39587-0ed9-4489-9483-caf57fbe2194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cd54536b-ccaf-4419-8a0e-0dc0dc687e69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_58d50f60-5420-401d-a60c-1266f7e94f93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cd54536b-ccaf-4419-8a0e-0dc0dc687e69" xlink:to="loc_us-gaap_AssetsCurrent_58d50f60-5420-401d-a60c-1266f7e94f93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0d6d0a7c-36c8-49cf-8dae-55bcbe68a0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cd54536b-ccaf-4419-8a0e-0dc0dc687e69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0d6d0a7c-36c8-49cf-8dae-55bcbe68a0e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_28dd5a1b-5437-40ce-9256-09de98079891" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cd54536b-ccaf-4419-8a0e-0dc0dc687e69" xlink:to="loc_us-gaap_Goodwill_28dd5a1b-5437-40ce-9256-09de98079891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_56c20d50-c940-4846-b241-250f01c7f530" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cd54536b-ccaf-4419-8a0e-0dc0dc687e69" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_56c20d50-c940-4846-b241-250f01c7f530" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="flks-20200331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="simple" xlink:href="flks-20200331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5d2945bd-4dc9-4020-85f7-eaee029ff25f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_64361453-8943-42c9-b15e-6ebe6f29d11e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5d2945bd-4dc9-4020-85f7-eaee029ff25f" xlink:to="loc_us-gaap_OperatingExpenses_64361453-8943-42c9-b15e-6ebe6f29d11e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d728e639-fcc4-47f3-a20b-a2b715124850" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5d2945bd-4dc9-4020-85f7-eaee029ff25f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d728e639-fcc4-47f3-a20b-a2b715124850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8c56f895-094e-4a0e-8bc5-72749a4a38a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2f70dbe7-18b8-4999-a434-34d94aae7e54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8c56f895-094e-4a0e-8bc5-72749a4a38a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2f70dbe7-18b8-4999-a434-34d94aae7e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d090d7a8-9fb5-456a-9c2c-71ce7dc682c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8c56f895-094e-4a0e-8bc5-72749a4a38a5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d090d7a8-9fb5-456a-9c2c-71ce7dc682c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_663a9b9b-7382-492f-a837-306c810d4e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_44df3611-c8f9-43ca-b1f1-418c7868971f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_663a9b9b-7382-492f-a837-306c810d4e1a" xlink:to="loc_us-gaap_OperatingIncomeLoss_44df3611-c8f9-43ca-b1f1-418c7868971f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_28643b0b-e3cb-40c0-8884-7aa3d0ce06d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_663a9b9b-7382-492f-a837-306c810d4e1a" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_28643b0b-e3cb-40c0-8884-7aa3d0ce06d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_32522189-b29e-4a0c-b0dc-1c82c3892348" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_663a9b9b-7382-492f-a837-306c810d4e1a" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_32522189-b29e-4a0c-b0dc-1c82c3892348" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="flks-20200331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09bc0a4a-0392-49b7-a36c-8b6b32307bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_7ed9fc7b-3733-48a1-81ef-3b0244c882bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09bc0a4a-0392-49b7-a36c-8b6b32307bbf" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_7ed9fc7b-3733-48a1-81ef-3b0244c882bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_e6baa514-50d2-4a65-b114-ed1631d2104c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_09bc0a4a-0392-49b7-a36c-8b6b32307bbf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_e6baa514-50d2-4a65-b114-ed1631d2104c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c59d6f1-d0a4-40f9-924a-6d9709ac3122" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bb2d8d63-407e-40d2-b989-425d4f832bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c59d6f1-d0a4-40f9-924a-6d9709ac3122" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bb2d8d63-407e-40d2-b989-425d4f832bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bbebbb76-f5a9-469d-97bc-1492553ed902" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c59d6f1-d0a4-40f9-924a-6d9709ac3122" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bbebbb76-f5a9-469d-97bc-1492553ed902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f87c04f1-1499-4a53-9a4c-42ce20dc2563" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_ShareBasedCompensation_f87c04f1-1499-4a53-9a4c-42ce20dc2563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_af182fd9-1b48-45de-8d7c-ed3a5ce5117e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_af182fd9-1b48-45de-8d7c-ed3a5ce5117e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f8429e22-193a-45d9-b732-81db529a1588" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f8429e22-193a-45d9-b732-81db529a1588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ae233bb9-5e69-4ef8-a339-7eb4bd51e53e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ae233bb9-5e69-4ef8-a339-7eb4bd51e53e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_3203597c-d099-4c58-9d0a-72389e616e5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_3203597c-d099-4c58-9d0a-72389e616e5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedParties_000896b2-e4a7-4261-a26e-4ee5bc079134" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedParties_000896b2-e4a7-4261-a26e-4ee5bc079134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d584a2c-6a91-40ca-b1d0-ff5e8f5974c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_NetIncomeLoss_9d584a2c-6a91-40ca-b1d0-ff5e8f5974c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_be71bd7b-fa63-4c33-96b3-abc4aaa8f9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_be71bd7b-fa63-4c33-96b3-abc4aaa8f9ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9ce04aa2-9cf2-4759-8671-b8e235e0a612" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9ce04aa2-9cf2-4759-8671-b8e235e0a612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_e805d856-3503-4122-84f5-58ba3c85b314" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e8e97f7-4726-4957-ad66-cb8224273ed0" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_e805d856-3503-4122-84f5-58ba3c85b314" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITUnaudited" xlink:type="simple" xlink:href="flks-20200331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITUnaudited"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITUnaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="simple" xlink:href="flks-20200331.xsd#ORGANIZATIONANDOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="flks-20200331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="flks-20200331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSAL"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSALTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSALNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9feda236-f4c9-4e46-8813-0f7be7071cce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a83f4651-91e6-4cbb-bb9a-7e7cb8cdfaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9feda236-f4c9-4e46-8813-0f7be7071cce" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a83f4651-91e6-4cbb-bb9a-7e7cb8cdfaf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_04e30d2c-6f0b-473c-bf9d-9eaaaa3c3e4a" xlink:href="flks-20200331.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9feda236-f4c9-4e46-8813-0f7be7071cce" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_04e30d2c-6f0b-473c-bf9d-9eaaaa3c3e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_39f8b9a9-dcda-40e5-b641-5f558e0a8a58" xlink:href="flks-20200331.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9feda236-f4c9-4e46-8813-0f7be7071cce" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_39f8b9a9-dcda-40e5-b641-5f558e0a8a58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e7f5f19c-cca5-43d1-9aee-76b46b8a1594" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e7f5f19c-cca5-43d1-9aee-76b46b8a1594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbbbd1c2-6476-41e1-b600-b235680faa3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbbbd1c2-6476-41e1-b600-b235680faa3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e16e0756-4740-4e28-82be-318b46a235c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e16e0756-4740-4e28-82be-318b46a235c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_cd9d69f0-80ff-4d46-a8d1-8d03fef4637a" xlink:href="flks-20200331.xsd#flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:to="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_cd9d69f0-80ff-4d46-a8d1-8d03fef4637a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f658ff44-f97b-45c9-9f38-9a2df66b2b98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_da0a7a7b-d19a-42e8-af1f-b75ea1338f17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f658ff44-f97b-45c9-9f38-9a2df66b2b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4de98549-6663-4ad8-9fcd-7221719a4977" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_60185ad1-5adb-45a6-9bb3-72a1538a3fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4de98549-6663-4ad8-9fcd-7221719a4977" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_60185ad1-5adb-45a6-9bb3-72a1538a3fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_807b0fd9-37ec-42ac-b727-6ca33e8fa1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2a9cdcc6-ad06-4f8e-a3b1-d67dc30ece74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_807b0fd9-37ec-42ac-b727-6ca33e8fa1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2a9cdcc6-ad06-4f8e-a3b1-d67dc30ece74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_fbe05f8a-426b-444f-85fd-df95edbb05ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_807b0fd9-37ec-42ac-b727-6ca33e8fa1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_fbe05f8a-426b-444f-85fd-df95edbb05ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/GRANTSRECEIVABLE" xlink:type="simple" xlink:href="flks-20200331.xsd#GRANTSRECEIVABLE"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/GRANTSRECEIVABLE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/GRANTSRECEIVABLEDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#GRANTSRECEIVABLEDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/GRANTSRECEIVABLEDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="simple" xlink:href="flks-20200331.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="simple" xlink:href="flks-20200331.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_100ae25f-30bc-4192-80b5-4e5dc4a6ccee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4ea30e18-d7cb-4e10-8bac-3d84e23c2fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_100ae25f-30bc-4192-80b5-4e5dc4a6ccee" xlink:to="loc_us-gaap_OtherAssetsCurrent_4ea30e18-d7cb-4e10-8bac-3d84e23c2fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_PrepaidClinicalTrialExpense_f8e9442d-4b89-459c-90b1-daf969625359" xlink:href="flks-20200331.xsd#flks_PrepaidClinicalTrialExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_100ae25f-30bc-4192-80b5-4e5dc4a6ccee" xlink:to="loc_flks_PrepaidClinicalTrialExpense_f8e9442d-4b89-459c-90b1-daf969625359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_3743084b-c23a-439a-934f-2f35e115074c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_100ae25f-30bc-4192-80b5-4e5dc4a6ccee" xlink:to="loc_us-gaap_PrepaidInsurance_3743084b-c23a-439a-934f-2f35e115074c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="flks-20200331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="flks-20200331.xsd#FAIRVALUEOFFINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="flks-20200331.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="flks-20200331.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="flks-20200331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="simple" xlink:href="flks-20200331.xsd#EQUITYBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="flks-20200331.xsd#EQUITYBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#EQUITYBASEDCOMPENSATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="flks-20200331.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="flks-20200331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended"/>
</link:linkbase>
